Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis April 1, 2021 J Clin Aesthet Dermatol. 2021;14(4):E53–E60. by Hilary E. Baldwin, MD; Lawrence J. CONTINUE READING »